Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
Lung cancer is considered the most commonly diagnosed cancer and one of the leading causes of death globally. Despite the responses from small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) patients to conventional chemo- and radiotherapies, the current outcomes are not satisfactory....
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2022-11-01
|
| Reeks: | Pharmaceuticals |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1424-8247/15/12/1475 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|